Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOLI: Mifepristone Outpatient Labour Induction
NCT05177510Phase 2Recruiting
- Sponsor
- Chelsea and Westminster Hospital NHS Foundation Trust
- Start
- Aug 2023
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in labor induction comparing Mifepristone and standard of care with Placebo (2 arms). Primary endpoint: Measure of women in labour or delivered within 2 days of intervention. Started Aug 2023; status: recruiting.
02
Drugs
mifepristone
03
Conditions
labor induction
Beyond the preview
Go deeper on NCT05177510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05177510.